StockTitan

@stocktitan.net

3 days ago

BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States BioHarvest Sciences (NASDAQ: BHST) announced that VINIA is the No.1 Resveratrol Polyphenol nutraceutical brand in the United States as of March 26, 2026.Key metrics: U.S. revenue > $30 million in 2025, $85 million global cumulative revenue to date, ~85,000 active users, and VINIA.com accounts for ~80% of U.S. VINIA revenue. The company cites Botanical Synthesis technology that preserves plant-cell structure and magnifies piceid resveratrol up to 100x. The #1 ranking is based on NIQ 2025 market projections and Amazon sales estimates.

#BHST BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

2 months ago

BioHarvest Sciences Issues Year End Shareholder Letter BioHarvest Sciences Inc. , (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from

#BHST BioHarvest Sciences Issues Year End Shareholder Letter

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

3 months ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform BioHarvest (NASDAQ: BHST) was awarded a $1.6 million grant from the Israeli Innovation Authority under its Bio-Convergence program on December 18, 2025.The non-dilutive, zero-interest loan will fund development of the company’s second-generation Botanical Synthesis™ platform, including AI tools for process optimization, larger bioreactors for higher-volume production, and expanded autonomous manufacturing to improve scalability and unit economics.BioHarvest reports it is fully funded for current plans with approximately $25 million in cash; repayment of the IIA loan is contingent on predefined commercial milestones and expected to be paid from future project revenues.

#BHST BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

3 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company

#BHST BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

4 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results Strong VINIA Momentum and New CDMO Win Delivers 39% Year-Over-Year Growth Company Fortifies Balance Sheet with Recent $19.9 Million Instiutional Equity Raise Following $14.7 Million Strengthening of Balance Sheet via Accelerated Warrant Exercises and Debt-to-Equity Conversions in September

#BHST BioHarvest Sciences Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

4 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology platform, announces the pricing of an underwritten public

#BHST BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

www.stocktitan.net/news/BHST/bio-harvest-sc...

Small Cap Strategist

@smcapstrategist.bsky.social

4 months ago

Small-cap stocks in new ADX downtrend, Thu Nov 6th - #FTFT #GYRE #HTLD #DMLP #CVAC #INGN #JSPR #BHST #KPRX #MXCT #AIOT #WDH #SITC #NPB #NOTE #MED #JBI #DEA #CNMD #BLND #SGN #KAPA #UAVS #VVPR #TRNS #RPD #PSEC - More: crystalequityresearch.com/trade-alerts... - #smallcap

StockTitan

@stocktitan.net

4 months ago

BioHarvest Announces Proposed Public Offering of Common Stock BioHarvest (NASDAQ: BHST) announced on November 6, 2025 its intent to conduct an underwritten public offering of common stock, with Craig-Hallum as sole managing underwriter.The company said it may grant the underwriter a 30-day option to buy up to an additional 15% of the shares. Proceeds are expected to be used for R&D, manufacturing, marketing, advancing the CDMO business unit, debt reduction or refinancing, capital expenditures, and general corporate purposes. The offering is subject to market conditions and filing of a preliminary prospectus supplement to the SEC.

#BHST BioHarvest Announces Proposed Public Offering of Common Stock

www.stocktitan.net/news/BHST/bio-harvest-an...

StockTitan

@stocktitan.net

4 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis Partnership with "Saffron Tech" to Advance Production of One of the World's Most Valuable Botanicals Management Concurrently Shares Third Quarter 2025 Preliminary Results and Provides Guidance for the Fourth Quarter of 2025 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October

#BHST BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

www.stocktitan.net/news/BHST/bio-harvest-sc...

Small Cap Strategist

@smcapstrategist.bsky.social

6 months ago

Small-cap stocks with improving money flow, Tue Sept 23rd - #SAVA #PDYN #NUTX #IMTX #GSIT #FAT #EM #CYCN #BHST #ATRA #VEL #SPI - More: crystalequityresearch.com/leading-indi... - #smallcap

StockTitan

@stocktitan.net

6 months ago

$14.7M Financial Boost: BioHarvest Sciences Strengthens Position with Major Warrant Exercise and Debt Reduction Biotech firm raises $10.9M through warrant exercises and convertible notes, while reducing debt by $3.8M. Total debt now at $6.6M. Funds targeted for capacity expansion and refinancing.

#BHST BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

6 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale BioHarvest Sciences (NASDAQ: BHST) has achieved a significant breakthrough in its Botanical Synthesis platform by successfully producing plant-based exosomes at scale in its bioreactor media. These nano-sized vesicles, naturally secreted by plant cells, offer enhanced absorption and bioavailability compared to regular plant compounds.The company's bioreactors, which combine optimized growth media with light-permeable technology, produce exosomes containing viniferin, a polyphenol valued for skincare applications. This development positions BioHarvest to enter the global exosome market, projected to grow from $0.7B in 2025 to $2.2B by 2030. The company expects to launch a new skincare application within 18-24 months.

#BHST BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

7 months ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results BioHarvest Sciences (NASDAQ: BHST) reported strong Q2 2025 financial results with revenue growing 41% year-over-year to $8.5 million and gross margins expanding to 60%. The company's VINIA® product line continues to perform well, with 65,000 active U.S. users and over $60 million in cumulative revenue since its 2021 launch.Key developments include securing new CDMO contracts, launching VINIA® Daily Chews 2X Formula, and advancing three growth initiatives: a Health Pros affiliate program, entry into the electrolyte drinks market, and an AI-enabled CDMO discovery service. Management expects Q3 2025 revenues of at least $9.1 million and projects reaching adjusted EBITDA breakeven in Q4 2025.

#BHST BioHarvest Sciences Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

10 months ago

AI Breakthrough: BioHarvest's New Technology Could Save Endangered Plants While Revolutionizing Fragrance Industry BioHarvest deploys AI-driven botanical synthesis to produce rare fragrance compounds, targeting billion-dollar market while preserving threatened species. See development roadmap.

#BHST BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

www.stocktitan.net/news/BHST/bio-harvest-se...

StockTitan

@stocktitan.net

10 months ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results BioHarvest Sciences (NASDAQ: BHST) reported strong Q1 2025 financial results, with revenue growing 47% year-over-year to $7.9 million, exceeding management guidance. Gross margins expanded to 58.5%, up 227 basis points. The company's VINIA® subscriber base surpassed 50,000 with $50M cumulative revenue since launch. Management projects Q2 2025 revenues of at least $8.5 million and expects to reach adjusted EBITDA breakeven in H2 2025. The company's CDMO division achieved significant milestones, completing Stage 1 development for a Nasdaq-listed pharmaceutical company contract. Despite revenue growth, the company reported a net loss of $2.3 million ($0.13 per share), improved from a $6.6 million loss in Q1 2024. Cash position stood at $3.4 million after raising $3.9 million in debt financing.

#BHST BioHarvest Sciences Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

10 months ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company BioHarvest Sciences (NASDAQ: BHST) has successfully completed Stage 1 of its CDMO contract with an unnamed Nasdaq-listed pharmaceutical company and is advancing to Stage 2. The project, which began in early 2024, demonstrates the capability of BioHarvest's Botanical Synthesis platform to develop active pharmaceutical compounds.In Stage 1, BioHarvest's research team successfully isolated target plant cells and replicated them using their proprietary platform. Stage 2 will focus on producing sufficient biomass for testing and developing optimal growing conditions in liquid media. Upon success, the project will progress to small and medium-scale production before moving to commercial volume production.This milestone validates the platform's versatility and positions BioHarvest as a trusted partner in providing scalable, cost-effective alternatives to traditional compound sourcing for pharmaceutical, nutrition, and nutraceutical industries.

#BHST BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

www.stocktitan.net/news/BHST/bio-harvest-an...

StockTitan

@stocktitan.net

11 months ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results BioHarvest Sciences (NASDAQ: BHST) reported strong Q4 2024 financial results with revenues growing 62% to $7.3 million, exceeding guidance. Full-year 2024 revenues increased 99% to $25.2 million with gross margins expanding 1,000 basis points to 55%.Key highlights include a CDMO partnership with Tate & Lyle for plant-based sweeteners development, successful Nasdaq Global Market uplisting, and VINIA® subscribers surpassing 50,000. The company launched VINIA® SuperFood tea line following successful coffee line introduction which generated $2.3 million since December 2023.Q4 gross profit increased 80% to $4.1 million (56.7% margin), while marketing expenses decreased to 40.4% of revenue. Management projects Q1 2025 revenues of at least $7.8 million and expects adjusted EBITDA breakeven in H2 2025. The company ended Q4 with $2.4 million cash, subsequently raising $3.9 million in debt financing.

#BHST BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

1 year ago

Can BioHarvest's Olive Compound Tackle the Disease Affecting 40% of Americans? Early testing shows BioHarvest's Olive Cell compound reduces fat in liver cells, targeting a condition affecting 30-40% of US adults with commercial launch planned for 2026.

#BHST BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

www.stocktitan.net/news/BHST/bio-harvest-in...

StockTitan

@stocktitan.net

1 year ago

Breakthrough Health Supplement VINIA Reaches $50M Sales: Inside BioHarvest's Rapid US Market Success BioHarvest's VINIA supplement achieves $50M in sales, backed by 4.8/5 rating from 8,000 reviews. Company announces major production expansion for 2026.

#BHST BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

www.stocktitan.net/news/BHST/bio-harvest-an...

StockTitan

@stocktitan.net

1 year ago

BioHarvest Sciences Doubles Subscriber Base, Launches CDMO Division with Tate & Lyle Partnership BioHarvest's VINIA® business reaches 50,000 US subscribers, hits $30M run rate. New CDMO division and coffee line launch drive 56% margins as company targets 2025 profitability.

#BHST BioHarvest Issues Shareholder Letter and Provides Corporate Update

www.stocktitan.net/news/BHST/bio-harvest-is...

StockTitan

@stocktitan.net

1 year ago

Tate & Lyle Partners with BioHarvest Sciences to Revolutionize Plant-Based Sweeteners Using Breakthrough Technology Major partnership combines Tate & Lyle's industry expertise with BioHarvest's innovative Botanical Synthesis platform to develop sustainable, sugar-like sweeteners without aftertaste.

#BHST Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

#news #stocks #investing

www.stocktitan.net/news/BHST/tate-lyle-and-...

StockTitan

@stocktitan.net

1 year ago

#BHST BioHarvest Sciences Reports Third Quarter 2024 Financial Results

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

1 year ago

#BHST BioHarvest Launches VINIA SuperFood Functional Tea Line

www.stocktitan.net/news/BHST/bio-harvest-la...

StockTitan

@stocktitan.net

1 year ago

#BHST BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

www.stocktitan.net/news/BHST/bio-harvest-sc...

StockTitan

@stocktitan.net

1 year ago

#BHST BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

www.stocktitan.net/news/BHST/bio-harvest-sc...